Drug Database
Back to search

Poland· PL-100398904

Coroswera

A rosuvastatin and ezetimibe product containing rosuvastatinum + ezetimibum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 9 of our 19 countries.

ATC C10BA06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCorosweraATCC10BA06REGISTER NO.PL-100398904PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rosuvastatinum + ezetimibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rosuvastatin and ezetimibe is registered in 9 of 19 countries.

Countries holding a registration under ATC C10BA06 (rosuvastatin and ezetimibe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search rosuvastatin and ezetimibe products by name

Rosuvastatin and ezetimibe · ATC C10BA06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Rosuvastatinum + Ezetimibum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
C10BA06
ATC class
Rosuvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

2 priced
  • gtin
    05909991397456
    30 szt.
    PLN 23.88
  • gtin
    05909991397494
    90 szt.
    PLN 65.84
  • gtin
    05909991397470
  • gtin
    05909991397463
  • gtin
    05909991397487
  • gtin
    05909991397500

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin and ezetimibe in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Arosuva Plus Ezetimib, Ezerosu
  • Belgium · Cholecomb, Ezetimibe/Rosuvastatin Sandoz
  • Bulgaria · Rosteza 10 Mg/10 Mg, Rosteza 20 Mg/10 Mg
  • Cyprus · Celmantin Plus, Lipocomb
  • Czechia · Delipid Plus, Refidoro
  • Germany · Antilia, Ezehron Duo
  • Estonia · Delipid Plus, Rosazimib
  • Spain · Alzil Plus, Arrox Plus
  • Finland · Rosuvastatin/Ezetimib Krka, Rosuvastatin/Ezetimibe Ratiopharm
  • France · Liporosa, Quiloga
  • Greece · Celmantin Plus, Co-Rosuvador
  • Croatia · Arosen, Co-Roswera
  • Hungary · Co-Xeter, Delipid Plus
  • Ireland · Lipocomb, Rosuvastatin/Ezetimibe Krka
  • Italy · Aurozeb, Cholecomb
  • Lithuania · Roselia, Sorvitimb
  • Luxembourg · Cholecomb, Myrosor
  • Latvia · Rosazimib, Rosulip
  • Malta · Ezehron Duo, Lipocomb
  • Netherlands · Ayadont, Cholecomb
  • Norway · Rosteze, Rosuvastatin/Ezetimib Krka
  • Portugal · Colroset, Lipocomb
  • Romania · Co-Roswera, Lipocomb
  • Slovenia · Refidoro, Rozor
  • Slovakia · Lipocomb, Rosazimib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/917b2fe8-9946-4226-985f-15146df2ea41
GET /v1/drugs/917b2fe8-9946-4226-985f-15146df2ea41?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "5 mg + 10 mg",
  "packaging": "05909991397456 ¦ Rp ¦ 131912\n30 tabl.\n05909991397463 ¦ Rp ¦ 131913\n56 tabl.\n05909991397470 ¦ Rp ¦ 131914\n60 tabl.\n05909991397487 ¦ Rp ¦ 131915\n84 tabl.\n05909991397494 ¦ Rp ¦ 131916\n90 tabl.\n05909991397500 ¦ Rp ¦ 131917\n98 tabl.",
  "substance": "Rosuvastatinum 5 mg + Ezetimibum 10 mg",
  "common_name": "Rosuvastatinum + Ezetimibum",
  "pl_product_id": "100398904",
  "pozwolenie_nr": "25209",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about rosuvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console